作者: Nicholas Reed
DOI: 10.1007/978-3-642-13492-0_14
关键词: Pathology 、 Struma ovarii 、 Pathological 、 Thyroid 、 Neuroendocrine differentiation 、 Carcinoid syndrome 、 Endocrine system 、 Ovary 、 Ovarian Teratoma 、 Medicine
摘要: Ovarian carcinoids were first described in 1939 by Stewart et al. [1]. Most commonly ovarian will be metastatic rather than primary [2–14, 41]. Of the carcinoids, insular pattern is most seen. Carcinoids arising within or associated with an teratoma are also relatively common but vary pathological subtype. Today, it preferable to adopt new nomenclature adopted WHO classification of Neuroendocrine Tumours (NETs) as deployed other sites, although conceded, old terminology used and remains familiar many clinicians [15, 16]. As well trabecular (with ribbon pattern) strumal tumours capable thyroid differentiation. Distinguishing advanced from carcinoid not always easy tend involve one ovary whereas disease usually involves both ovaries. It suggested that may a mature ipsilateral sometimes contralateral [4, 5, 7, 8, 14, 17]. Finally, goblet cell described, which probably adenocarcinomas, some degree neuroendocrine differentiation collision occasionally described. The refers these mixed endocrine–exocrine cancers (MEEC), term more useful [18]. This topic mucinous masterfully reviewed Young [19, 20].